In a patient with hyponatremia, which diuretic is preferred: hydrochlorothiazide (HCTZ) or spironolactone?

In a patient with hyponatremia, avoid hydrochlorothiazide (HCTZ) and prefer spironolactone if diuresis is needed.

HCTZ is strongly associated with causing and worsening hyponatremia, while spironolactone does not typically cause this electrolyte disturbance. In fact, the evidence shows that thiazide diuretics like HCTZ are a well-recognized cause of hyponatremia, whereas spironolactone (a potassium-sparing diuretic) works through a different mechanism that does not predispose to sodium loss.

Key Evidence on Thiazide-Induced Hyponatremia

The literature consistently demonstrates that thiazide diuretics are a major cause of hyponatremia:

• Both loop diuretics and thiazides list hyponatremia as a major side effect 1
• HCTZ specifically "can cause rapid development of hyponatremia" even when added to other diuretic regimens 2
• Recent case reports document severe, early-onset thiazide-induced hyponatremia leading to seizures, occurring as quickly as 3 days after initiation 3
• A large retrospective study confirmed higher rates of hyponatremia with thiazides compared to other diuretic classes 4

Spironolactone's Safety Profile Regarding Sodium

Spironolactone does not cause hyponatremia. Its mechanism of action—aldosterone antagonism at the distal tubule—promotes sodium and water excretion while retaining potassium 5. The primary electrolyte concern with spironolactone is hyperkalemia, not hyponatremia 1.

In cirrhosis guidelines, where hyponatremia is common, spironolactone is the preferred first-line diuretic 2, 6. The 2009 hepatology guidelines specifically note that "hydrochlorothiazide can cause rapid development of hyponatremia when added to the combination of spironolactone and furosemide" 2.

Clinical Algorithm for Diuretic Selection in Hyponatremia

If the patient already has hyponatremia:

• Stop HCTZ immediately if currently prescribed
• If diuresis is needed, use spironolactone (starting 25-100 mg daily) 6, 7
• Monitor potassium closely (every 5-7 days initially) to avoid hyperkalemia 1
• Consider loop diuretics (furosemide) as an alternative, though they also carry hyponatremia risk 1

If the patient needs diuretic therapy but has borderline-low sodium (130-135 mmol/L):

• Avoid thiazides entirely
• Prefer spironolactone or loop diuretics
• Monitor sodium levels within 1-2 weeks of initiation 8

If severe hyponatremia exists (sodium <125 mmol/L):

• Discontinue all diuretics temporarily if possible 7
• Implement fluid restriction (1-1.5 L/day) 2, 7
• Address underlying causes
• Once stabilized, if diuresis remains necessary, use spironolactone with close monitoring

Important Caveats

The combination of spironolactone with ACE inhibitors or ARBs increases hyperkalemia risk 1, 5. In patients on these medications:

• Start with lower spironolactone doses (25 mg daily)
• Check potassium and creatinine every 5-7 days until stable 1
• Avoid potassium supplements
• Consider amiloride as an alternative if hyperkalemia develops, though it's less effective 2

In heart failure patients, the 2013 ACC/AHA guidelines list hyponatremia as a side effect of both thiazides and loop diuretics but do not list it for spironolactone 8. This further supports spironolactone's relative safety regarding sodium balance.

The mechanism matters: Thiazides impair free water clearance in the distal tubule, leading to dilutional hyponatremia. Spironolactone's aldosterone antagonism promotes natriuresis without this same impairment in water handling 5.

Bottom Line

Choose spironolactone over HCTZ in any patient with existing or at-risk hyponatremia. The evidence is clear that thiazides cause hyponatremia while spironolactone does not. Monitor potassium instead of sodium as your primary electrolyte concern with spironolactone, especially in patients on ACE inhibitors or ARBs 1, 6, 7.